Authors
Loading...
Randomized trial demonstrates atypical DNA damage responses in senescent cells, suggesting new biomarker potential.
Pospelova et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: